Opportunity at National Institute of Standards and Technology (NIST)
Metrology for Genome Editing
Material Measurement Laboratory, Biosystems and Biomaterials Division
Please note: This Agency only participates in the February and August reviews.
|Maragh, Samantha Denise
Genome editing technologies enable targeted DNA sequence changes to be made in the cells organisms. Genome editing is being actively pursued to transform precision medicine and bioscience in areas such as cell therapy, synthetic biology, novel antimicrobials and antivirals, protein therapeutic biomanufacturing, agriculture, and global food production. Moving the promise of these technologies into production and precision medicine requires high confidence characterization of the genome editing pipeline, particularly as it pertains to the generation of intended and unintended DNA sequence changes. The genome editing community recognizes this is a critical need, which is difficult to address. Research will focus on developing tools, robust quantitative assays, and reliable measurement infrastructure to meet measurement assurance needs for the genome editing field.
Gene editing; Biology; CRISPR; Cas9; Genetics; Genome; Molecular; Cell; Precision medicine;
Open to U.S. citizens
Open to Postdoctoral applicants